Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€9.33
27.12.22
-
27.12.23
-57.45%
06.01.23

Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.64
27.12.22
-
27.12.23
8.64%
24.04.23

Growths faster than the competition
Risky Investment
Codexis Inc.

Start price
Target price
Perf. (%)
€3.99
27.12.22
-
27.12.23
-6.46%
24.04.23

Probably not worthwhile Investment
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.75
26.12.22
-
26.12.23
48.74%
05.02.23

Risky Investment
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.33
24.12.22
€7.00
31.12.25
-8.10%
09.01.23

Could be very worthwhile Investment >20% year
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€5.09
24.12.22
€8.00
31.12.25
-45.23%
05.05.23

Could be very worthwhile Investment >20% year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.19
24.12.22
-
24.12.23
5.50%
25.12.23

Could be worthwhile Investment >10% per year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€7.52
23.12.22
€9.00
30.09.25
-79.54%
12.11.23

Could be very worthwhile Investment >20% year
buy
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€2.05
21.12.22
€4.00
31.12.24
-34.96%
05.05.23

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.32
21.12.22
€11.00
31.03.24
29.21%
28.12.22

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.76
11.12.22
-
11.12.23
-6.82%
06.03.23

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.85
17.11.22
-
17.11.23
-17.52%
27.11.22

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€7.15
13.11.22
-
13.11.23
-20.98%
26.11.22

Could be worthwhile Investment >10% per year
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.91
08.11.22
€4.20
08.11.23
23.85%
16.11.22

buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.62
03.11.22
-
03.11.23
13.26%
10.11.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
-
29.10.23
40.63%
30.10.23

Could be worthwhile Investment >10% per year
buy
Rocket Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€17.96
26.10.22
€28.00
31.12.24
15.29%
08.06.24

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.67
26.10.22
€35.00
31.12.24
-41.33%
21.12.22

Could be very worthwhile Investment >20% year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.78
25.10.22
€5.00
31.12.24
-23.55%
05.05.23

Could be very worthwhile Investment >20% year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€4.50
24.10.23
-3.11%
25.10.23

Could be worthwhile Investment >10% per year
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€7.00
24.10.23
18.42%
29.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
18.10.22
-
18.10.23
0.78%
29.10.22

Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.84
17.10.22
-
17.10.23
40.63%
18.05.23

Risky Investment